{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:44:35Z","timestamp":1786985075269,"version":"build-2736575974"},"reference-count":37,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.bcp.2011.08.003","type":"journal-article","created":{"date-parts":[[2011,8,15]],"date-time":"2011-08-15T06:47:16Z","timestamp":1313390836000},"page":"1747-1756","source":"Crossref","is-referenced-by-count":125,"title":["Human arylacetamide deacetylase is responsible for deacetylation of rifamycins: Rifampicin, rifabutin, and rifapentine"],"prefix":"10.1016","volume":"82","author":[{"given":"Akinori","family":"Nakajima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuki","family":"Fukami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinobu","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Yokoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2011.08.003_bib0005","doi-asserted-by":"crossref","unstructured":"Yamaoka T. Rifampicin use in MRSA infections in developing countries. Reply to the letter to the editor by D.S. Neogi. J Infect Chemother 2009;15:205.","DOI":"10.1007\/s10156-009-0688-6"},{"key":"10.1016\/j.bcp.2011.08.003_bib0010","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1159\/000386837","article-title":"Chemical and biological properties of rifampicin","volume":"16","author":"Fresz","year":"1970","journal-title":"Antibiot Chemother"},{"key":"10.1016\/j.bcp.2011.08.003_bib0015","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2165\/00003088-200140050-00002","article-title":"Comparative pharmacokinetics and pharmacodynamics of the rifamycin antibacterials","volume":"40","author":"Burman","year":"2001","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.bcp.2011.08.003_bib0020","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1080\/004982597239994","article-title":"Rifampin and rifabutin and their metabolism by human liver esterases","volume":"27","author":"Jamis-Dow","year":"1997","journal-title":"Xenobiotica"},{"key":"10.1016\/j.bcp.2011.08.003_bib0025","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1208\/s12248-009-9135-y","article-title":"Activation of pregnane X receptor (PXR) and constitutive androstane receptor (CAR) by herbal medicines","volume":"11","author":"Chang","year":"2009","journal-title":"AAPS J"},{"key":"10.1016\/j.bcp.2011.08.003_bib0030","doi-asserted-by":"crossref","first-page":"S327","DOI":"10.1093\/clinids\/12.Supplement_3.S327","article-title":"Drug interactions with fluconazole","volume":"12","author":"Lazar","year":"1990","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.bcp.2011.08.003_bib0035","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1440-1843.2006.00941.x","article-title":"Antituberculosis drugs and hepatotoxicity","volume":"11","author":"Yew","year":"2006","journal-title":"Respirology"},{"key":"10.1016\/j.bcp.2011.08.003_bib0040","first-page":"1072","article-title":"Rifampin-induced release of hydrazine from isoniazid. A possible cause of hepatitis during treatment of tuberculosis with regimens containing isoniazid and rifampin","volume":"133","author":"Sarma","year":"1986","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.bcp.2011.08.003_bib0045","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S0009-9236(97)90135-1","article-title":"Metabolism of rifabutin in human enterocyte and liver microsomes: kinetic parameters, identification of enzyme systems, and drug interactions with macrolides and antifungal agents","volume":"61","author":"Iatsimirskaia","year":"1997","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.bcp.2011.08.003_bib0050","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/jbt.20178","article-title":"Human carboxylesterases and their role in xenobiotic and endobiotic metabolism","volume":"21","author":"Ross","year":"2007","journal-title":"J Biochem Mol Toxicol"},{"key":"10.1016\/j.bcp.2011.08.003_bib0055","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0006-291X(91)92005-5","article-title":"Purification and characterization of a human liver arylacetamide deacetylase","volume":"177","author":"Probst","year":"1991","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bcp.2011.08.003_bib0060","doi-asserted-by":"crossref","first-page":"21650","DOI":"10.1016\/S0021-9258(17)31855-0","article-title":"Human liver arylacetamide deacetylase. Molecular cloning of a novel esterase involved in the metabolic activation of arylamine carcinogens with high sequence similarity to hormone-sensitive lipase","volume":"269","author":"Probst","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2011.08.003_bib0065","doi-asserted-by":"crossref","first-page":"5109","DOI":"10.1038\/sj.emboj.7601924","article-title":"An acetylation\/deacetylation cycle controls the export of sterols and steroids from S. cerevisiae","volume":"26","author":"Tiwari","year":"2007","journal-title":"EMBO J"},{"key":"10.1016\/j.bcp.2011.08.003_bib0070","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1124\/dmd.109.026567","article-title":"Human arylacetamide deacetylase is a principal enzyme in flutamide hydrolysis","volume":"37","author":"Watanabe","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.bcp.2011.08.003_bib0075","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1124\/dmd.110.033720","article-title":"Arylacetamide deacetylase is a determinant enzyme for the difference in hydrolase activities of phenacetin and acetaminophen","volume":"38","author":"Watanabe","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.bcp.2011.08.003_bib0080","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1124\/dmd.110.034454","article-title":"In vitro evaluation of inhibitory effects of antidiabetic and antihyperlipidemic drugs on human carboxylesterase activities","volume":"38","author":"Fukami","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.bcp.2011.08.003_bib0085","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1515\/bchm2.1967.348.1.609","article-title":"Phospholic acid-bis-(p-nitro-phenylester), a new inhibitor of microsomal carboxylesterases","volume":"348","author":"Heymann","year":"1967","journal-title":"Hoppe Seylers Z Physiol Chem"},{"key":"10.1016\/j.bcp.2011.08.003_bib0090","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2133\/dmpk.21.147","article-title":"Involvement of human blood arylesterases and liver microsomal carboxylesterases in nafamostat hydrolysis","volume":"21","author":"Yamaori","year":"2006","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.bcp.2011.08.003_bib0095","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1254\/jjp.15.244","article-title":"Studies on the classification of the enzymes hydrolysing ester-form drugs in liver microsomes","volume":"15","author":"Iwatsubo","year":"1965","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.bcp.2011.08.003_bib0100","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.3891\/acta.chem.scand.19-1333","article-title":"Action of fluoride on cholinesterase. I. On the mechanism of inhibition","volume":"19","author":"Heilbronn","year":"1965","journal-title":"Acta Chem Scand"},{"key":"10.1016\/j.bcp.2011.08.003_bib0105","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0161-5890(00)00104-8","article-title":"Cholinesterase-like catalytic antibodies: reaction with substrates and inhibitors","volume":"37","author":"Johnson","year":"2000","journal-title":"Mol Immunol"},{"key":"10.1016\/j.bcp.2011.08.003_bib0110","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/art.1780260414","article-title":"Identification and partial purification of the major aspirin hydrolyzing enzyme in human blood","volume":"26","author":"Costello","year":"1983","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bcp.2011.08.003_bib0115","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.tiv.2009.11.020","article-title":"An in vitro drug-induced hepatotoxicity screening system using CYP3A4-expressing and \u03b3-glutamylcysteine synthetase knockdown cells","volume":"24","author":"Hosomi","year":"2010","journal-title":"Toxicol In Vitro"},{"key":"10.1016\/j.bcp.2011.08.003_bib0120","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2133\/dmpk.19.103","article-title":"Differences in transactivation between rat CYP3A1 and human CYP3A4 genes by human pregnane X receptor","volume":"19","author":"Takada","year":"2004","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.bcp.2011.08.003_bib0125","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1158\/0008-5472.CAN-04-0166","article-title":"Human CYP1B1 is regulated by estradiol via estrogen receptor","volume":"64","author":"Tsuchiya","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2011.08.003_bib0130","first-page":"2605","article-title":"Human carboxylesterase 2 is commonly expressed in tumor tissue and is correlated with activation of irinotecan","volume":"8","author":"Xu","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bcp.2011.08.003_bib0135","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1124\/dmd.32.7.762","article-title":"Bioactivation of capecitabine in human liver: involvement of the cytosolic enzyme on 5\u2032-deoxy-5-fluorocytidine formation","volume":"32","author":"Tabata","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.bcp.2011.08.003_bib0140","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S0140-6736(52)92058-8","article-title":"Succinylcholine (succinoylcholine), muscle-relaxant of short action","volume":"1","author":"Bourne","year":"1952","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2011.08.003_bib0145","first-page":"1458","article-title":"The anticancer prodrug CPT-11 is a potent inhibitor of acetylcholinesterase but is rapidly catalyzed to SN-38 by butyrylcholinesterase","volume":"59","author":"Morton","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2011.08.003_bib0150","doi-asserted-by":"crossref","first-page":"33435","DOI":"10.1074\/jbc.M004543200","article-title":"Rabbit serum paraoxonase 3 (PON3) is a high density lipoprotein-associated lactonase and protects low density lipoprotein against oxidation","volume":"275","author":"Draganov","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2011.08.003_bib0155","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1006\/geno.1996.0225","article-title":"The human serum paraoxonase\/arylesterase gene (PON1) is one member of a multigene family","volume":"33","author":"Primo-Parmo","year":"1996","journal-title":"Genomics"},{"key":"10.1016\/j.bcp.2011.08.003_bib0160","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0006-2952(60)90061-7","article-title":"Arylesterases in blood: effect of calcium and inhibitors","volume":"5","author":"Erdos","year":"1960","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2011.08.003_bib0190","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1124\/dmd.111.038141","article-title":"Human paraoxonase 1 is the enzyme responsible for pilocarpine hydrolysis","volume":"39","author":"Hioki","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.bcp.2011.08.003_bib0170","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1136\/gut.15.3.220","article-title":"Sites of competition in the selective hepatic uptake of rifamycin-SV, flavaspidic acid, bilirubin, and bromsulphthalein","volume":"15","author":"Kenwright","year":"1974","journal-title":"Gut"},{"key":"10.1016\/j.bcp.2011.08.003_bib0175","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0140-6736(74)92381-2","article-title":"Rifampicin hepatitis. A clinical and histological study","volume":"16","author":"Scheuer","year":"1974","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2011.08.003_bib0180","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1365-2125.2005.02515.x","article-title":"Effect of rifampicin on the pharmacokinetics of pioglitazone","volume":"61","author":"Jaakkola","year":"2006","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.bcp.2011.08.003_bib0185","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/BF02776672","article-title":"Induction of rat liver bilirubin-conjugating enzymes and glutathione S-transferase by rifampicin","volume":"20","author":"Adachi","year":"1985","journal-title":"Gastroenterol Jpn"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295211006526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295211006526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T07:40:54Z","timestamp":1638258054000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295211006526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0006295211006526"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2011.08.003","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}